Experimental workflow and sample cytogenetics. (A) Experimental workflow and sample sizes after quality control. (B) Summary of annotation filtering and quality control across data sets. (C) Distribution of the retained samples across cytogenetic abnormalities (n = 1534). NOS, not otherwise specified.